Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
Actual shortage: | 218 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-04-24 | 2017-07-05 | 7728 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-05-10 | 2017-05-25 | 9957 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-06-13 | 2017-07-11 | 12701 |
APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2018-03-29 | 2018-07-03 | 44200 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-05-08 | 2018-07-03 | 48869 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-11-09 | 2019-01-17 | 66552 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69324 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2019-04-24 | 2019-07-19 | 82340 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2019-05-15 | 2019-07-05 | 84163 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2019-10-09 | 2019-12-02 | 95894 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-11-06 | 2024-01-05 | 209345 |
APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2023-11-10 | 2024-01-05 | 209948 |
APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2017-09-07 | 2017-10-16 | 21216 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-01 | 2018-01-03 | 27767 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-12-14 | 2018-03-06 | 32839 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 692 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2023-12-08 | 2023-12-22 | 212925 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2022-03-15 | 2022-05-20 | 156758 |
APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2022-03-15 | 2022-05-19 | 156762 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |